Peer Review History

Original SubmissionJanuary 13, 2021
Decision Letter - Marilyn J. Roossinck, Editor, Peter D. Nagy, Editor

Dear Dr. Cao,

Thank you very much for submitting your manuscript "Viromics unveils extraordinary genetic diversity of the family Closteroviridae in wild citrus" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

Your paper has been assessed by two reviewers, both felt this was an important and interesting study, but reviewer 1 pointed out a number of major flaws in the paper that must be addressed before it can be acceptable for publication. Given the importance of the issue, I am advising you to revise the paper taking into account all of the comments. These need to be addressed in the Manuscript. I would also encourage you to find a colleague with expertise in virus evolution who could join you in this work as a co-author. Given the amount of revision required, should you choose to continue the paper will be reviewed again.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Marilyn J. Roossinck

Guest Editor

PLOS Pathogens

Peter Nagy

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************

Your paper has been assessed by two reviewers, both felt this was an important and interesting study, but reviewer 1 pointed out a number of major flaws in the paper that must be addressed before it can be acceptable for publication. Given the importance of the issue, I am advising you to revise the paper taking into account all of the comments. These need to be addressed in the Manuscript. I would also encourage you to find a colleague with expertise in virus evolution who could join you in this work as a co-author. Given the amount of revision required, should you choose to continue the paper will be reviewed again.

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #1: This work describes discovery of the CTV and three novel closteroviruses in the wild citrus growing in its natural mountainous habitat in China. Given the significant negative impact of CTV on citrus industry worldwide and the potential of new emerging virus infections to affect citrus growers, this work provides important insight into understanding ecology and evolution of citrus-infecting closteroviruses. Moreover, the genomic layout of the new closteroviruses described in this study significantly broadens understanding of genomic and evolutionary plasticity of this rapidly growing virus family and is likely to contribute to revision of closterovirus phylogeny and taxonomy.

In its present form, however, this manuscript needs to be significantly revised and re-written to address a number of the following major comments concerned with the quality of presented analyses and writing.

Reviewer #2: This is an innovative paper is providing molecular evidence for previously unrealized cases of infections of wild citrus relatives by two novel virus species belonging to ampelovirus genera and a third virus representing a possible new genus in the Closteroviridae family. Besides extending the citrus virus and the closteroviridae catalogs, this ms shows the significance of natural reserves as potential sources of disease agents endangering cultivated crop plants. Furthermore locating two and possibly three of the Closteroviridae family genera representatives within a limited area of undisturbed natural reserve could also indicate on the close association of the family origin with wild citrus On the other hand the finding of 5 out of the seven main CTV strains reported throughout the citrus world, associated with these wild citrus relatives either indicates , that CTV also originated in this area or that the native vegetation became infested by CTV strains carried by long distance flying vectors derived from long distance cultivated citrus hosting these isolates. For completing this paper the authors are suggested to include a supplemental map indicating on the distances of commercially cultivated citrus in the surrounding areas of the reserve.

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #1: 1. The study would significantly benefit from providing data on: i) virus incidence (% of the wild plants infected with each of the 4 viruses); ii) occurrence of the mixed infections; iii) presence of disease symptoms in the screened wild plants and, most importantly, in the cultivated Morocco orange plants used for grafting. Although not strictly required, addition of such data would significantly expand the biological/plant pathological dimension of this work, which, at this point, is entirely focused on virus phylogenomics.

2. By and large, the data presentation and interpretation shows insufficient expertise of the authors in molecular biology of the closteroviruses and virus evolution in general. But a few telling examples are as follows: i) In Fig. 3, line 162 and elsewhere, the closterovirus ~60 KDa proteins are named ‘HSP90h’ (for homologs of HSP90 cellular molecular chaperones), a long obsolete notion refuted in the work by Napuli et al. (2003; PMID:12551975); ii) terms ‘intraspecies’ or ‘external genes’ are not in use in the field; iii) claiming that CiVB with monopartite genome is likely an ancestor of the criniviruses with split genomes is a run-away speculation that has no support in the data (in RdRP tree – Fig. 4 – CiVB is as divergent from criniviruses as it goes and so is CiVB CP in the same figure); iv) statement that some of the closterovirus genes that are not universally conserved in the family are under negative selection (e.g., lines 319-321) has no basis in presented data: gene gain and loss is one of the dominant processes in genome evolution that cannot possibly be branded as positive or negative selection; etc., etc.

3. The reliability of the conserved domain identification in this study is a suspect. In the lines 171-172, it is casually mentioned that CaAV-1 genome encodes two subunits of the DNA polymerase III: none of the RNA viruses known so far does encode any part of any DNA polymerase (there is no DNA phase in their replication cycles). If this is correct, such finding must be supported by identifying such domains in more than one isolate of this virus as well as presenting reliable, statistically robust multiple alignment of these subunits from CaAV-1 and diverse cellular organisms. Same is required for ‘divalent metal cations transport protein’ and ‘DEDDy 3’-5’ exonuclease (lines 176-178). If correct, the latter finding would be the only exonuclease encoded by RNA viruses in addition to those in coronaviruses, potentially a very significantly discovery suggestive of the proof-reading capability of this virus. Further, the lack of L-Pro in all three newly discovered viruses would be exceedingly surprising (if true) and more likely hints at rather low sensitivity of the employed search software.

4. The quality of language and writing in general are also significant problems. But a few beyond the pale examples are sentences in lines 18-23, 291, 336-338. The entire Discussion is excessively long and largely incoherent; the section ‘Unique mode…’ starting on line 236 belongs to Discussion in much briefer form (experimental confirmation of the lack of frameshift should be mentioned), many acronyms in the text were never spelled out etc., etc.

Reviewer #2: (No Response)

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #1: (No Response)

Reviewer #2: See above

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Bar-Joseph, Moshe

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here on PLOS Biology: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plospathogens/s/submission-guidelines#loc-materials-and-methods

Revision 1

Attachments
Attachment
Submitted filename: Response to editors and reviewers.docx
Decision Letter - Marilyn J. Roossinck, Editor, Peter D. Nagy, Editor

Dear Dr. Cao,

We are pleased to inform you that your manuscript 'Viromics unveils extraordinary genetic diversity of the family Closteroviridae in wild citrus' has been provisionally accepted for publication in PLOS Pathogens.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Marilyn J. Roossinck

Guest Editor

PLOS Pathogens

Peter Nagy

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************************************************

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #1: This work provides major contributions to understanding origins and evolution of viruses affecting crop production in general and citrus in particular. Focused on closteroviruses, it also discovers novel members of this family, potentially at the genus level and novel virus-associated genes likely acquired via HGT from host of co-infecting or commensal microbes. One of these genes encoding thaumatin-like protein hints at recruitment of host defense proteins for virus functions common among diverse viruses, whereas another, a homolog of riboexonuclease, suggest a tantalizing possibility for the proof-reading role in the RNA replication process so far known only for coronaviruses. The data are solid, discussions comprehensive and the writing style is concise and clear. By and large, this reviewer is very impressed with authors bringing this thoroughly revised manuscript to qualitatively different level by improving both the style and the essence of the scientific narrative.

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #1: None

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #1: The only minor comment is the tendency of the authors to nearly exclusively cite review articles rather than original research that established critical aspects of closterovirus molecular biology and evolution.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Valerian V. Dolja

Formally Accepted
Acceptance Letter - Marilyn J. Roossinck, Editor, Peter D. Nagy, Editor

Dear Dr. Cao,

We are delighted to inform you that your manuscript, "Viromics unveils extraordinary genetic diversity of the family Closteroviridae in wild citrus," has been formally accepted for publication in PLOS Pathogens.

We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .